The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts
The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Experts
分析師意見：GeneDx控股在6位專家眼中
The standing of GeneDx Hldgs among financial experts becomes clear with a thorough analysis...Analysts' ratings for GeneDx Hldgs (NASDAQ:WGS) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
過去季度對GeneDx控股（納斯達克：WGS）的分析師評級從看好到看淡不等，由6位分析師提供。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $43.5, a high estimate of $54.00, and a low estimate of $32.00. This current average has increased by 18.21% from the previous average price target of $36.80.
分析師分析的12個月價格目標提供了洞察，平均目標爲43.5美元，最高估值爲54.00美元，最低估值爲32.00美元。當前平均值比之前的36.80美元的平均價格目標增加了18.21%。
Decoding Analyst Ratings: A Detailed Look
分析師評級解讀：詳細解析
The standing of GeneDx Hldgs among financial experts becomes clear with a thorough analysis...
通過對最近分析師行動進行徹底...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間